Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Completed 11 Active not recruiting 11 Recruiting 9 Terminated 8 Withdrawn 2 Unknown 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Carboplatin 79 Cisplatin 74 Bevacizumab 62 Radiotherapy 59 Drug Therapy 57 Capecitabine 57 Oxaliplatin 56 tislelizumab 54 toripalimab 45 Paclitaxel 44 Gemcitabine 43 pembrolizumab 40 anlotinib 40 Specimen Handling 39 sintilimab 37 Cyclophosphamide 34 130-nm albumin-bound paclitaxel 34 Injections 30 Pemetrexed 28 camrelizumab 26 Surgical Procedures, Operative 26 Magnetic Resonance Spectroscopy 25 lenvatinib 24 apatinib 23 Docetaxel 23 Etoposide 22 S 1 (combination) 21 Fluorouracil 21 Immune Checkpoint Inhibitors 20 Biopsy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × encorafenib × Clear all

NCT07178717 2025-09-17

REFISH

Vall d'Hebron Institute of Oncology

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡